Literature DB >> 17982887

Low dose methylphenidate improves freezing in advanced Parkinson's disease during off-state.

L Pollak1, Y Dobronevsky, T Prohorov, S Bahunker, J M Rabey.   

Abstract

Five men with advanced idiopathic Parkinson's disease (PD) were examined to assess the effect of low dose methylphenidate (MPD) on gait. The patients were tested during "off" state before and two hours after the intake of 10 mg MPD while walking an "8 trajectory". The total walking time, total freezing time, number of freezing episodes and the non-freezing walking time were assessed. The obtained data were compared by the Wilcoxon Signed Rank test with a type I error rate of 0.05. The results showed a statistically significant improvement in all gait parameters after MPD intake. Moreover, a good correlation in the grade of improvement for each individual gait characteristic was found. The study demonstrates that low dose of MPD may improve gait, and especially freezing, in patients with severe PD, without the need for exogenous L-dopa. The mechanism of MPD action in patients with advanced PD is further discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982887     DOI: 10.1007/978-3-211-73574-9_17

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  14 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

2.  Methylphenidate : a treatment for Parkinson's disease?

Authors:  David Devos; Caroline Moreau; Arnaud Delval; Kathy Dujardin; Luc Defebvre; Regis Bordet
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

Review 3.  Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?

Authors:  Albert Y Hung; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

4.  Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.

Authors:  A J Espay; A K Dwivedi; M Payne; L Gaines; J E Vaughan; B N Maddux; J T Slevin; M Gartner; A Sahay; F J Revilla; A P Duker; R Shukla
Journal:  Neurology       Date:  2011-04-05       Impact factor: 9.910

Review 5.  Novel therapeutic strategies in Parkinson's disease.

Authors:  Peter Klivenyi; Laszlo Vecsei
Journal:  Eur J Clin Pharmacol       Date:  2009-10-16       Impact factor: 2.953

Review 6.  Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management.

Authors:  Samuel D Kim; Natalie E Allen; Colleen G Canning; Victor S C Fung
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

Review 7.  Pharmacological treatment in Parkinson's disease: Effects on gait.

Authors:  Katrijn Smulders; Marian L Dale; Patricia Carlson-Kuhta; John G Nutt; Fay B Horak
Journal:  Parkinsonism Relat Disord       Date:  2016-07-17       Impact factor: 4.891

8.  Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Roger L Albin; Martijn L T M Müller; Kelvin Chou
Journal:  US Neurol       Date:  2011-11-01

9.  The effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adults.

Authors:  Olivia M Farr; Sheng Zhang; Sien Hu; David Matuskey; Osama Abdelghany; Robert T Malison; Chiang-Shan R Li
Journal:  Int J Neuropsychopharmacol       Date:  2014-05-13       Impact factor: 5.176

10.  Executive function and dopamine response in Parkinson's disease freezing of gait.

Authors:  Travis H Turner; Federico Rodriguez-Porcel; Philip Lee; Katherine Teague; Lisa Heidelberg; Shonna Jenkins; Gonzalo J Revuelta
Journal:  Parkinsonism Relat Disord       Date:  2021-10-18       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.